- Home
- / Fortrea Clinical Research Unit
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Fortrea Clinical Research Unit financials data including stock price, CreditSafe score, income statement, and balance sheet.
Revenue
£44.2 M
FY, 2019
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|
| Revenue | 29.6M | 40.9M | 44.2M |
| Revenue growth, % | 37.8% | 8.1% | |
| Cost of goods sold | 1.0M | 9.6M | 9.5M |
| Gross profit | 28.6M | 31.3M | 34.7M |
| Gross profit margin, % | 96.5% | 76.5% | 78.6% |
| General and administrative expense | 18.3M | 20.3M | 18.6M |
| Operating expense total | 18.3M | 20.3M | 18.6M |
| EBIT | 10.3M | 10.9M | 16.1M |
| EBIT margin, % | 34.8% | 26.8% | 36.4% |
| Interest income | 140.0K | 360.0K | 433.0K |
| Interest expense | 170.0K | 57.0K | 57.0K |
| Pre tax profit | 1.1M | 11.3M | 16.5M |
| Income tax expense | 962.0K | 1.8M | 227.0K |
| Net Income | 9.3M | 9.4M | 16.2M |